Korro Bio annual return on equity
2019
2020
2021
2023
2024
2025
Korro Bio Return on Equity (ROE) Growth & History (KRRO)
Korro Bio's return on equity was −110.70% for fiscal 2025.
View full Korro Bio company overviewKorro Bio annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −110.70% | −60.09 pp |
| 2024 | 2024-12-31 | −50.61% | +178.44 pp |
| 2023 | 2023-12-31 | −229.04% | — |
| 2021 | 2021-12-31 | −112.70% | −97.97 pp |
| 2020 | 2020-12-31 | −14.73% | +16.75 pp |
| 2019 | 2019-12-31 | −31.49% | — |
Korro Bio quarterly return on equity
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −16.98% | +3.31 pp |
| Q1 2026 | 2026-03-31 | −22.94% | −7.32 pp |
| Q4 2025 | 2025-12-31 | −66.51% | −54.05 pp |
| Q3 2025 | 2025-09-30 | −16.87% | −5.75 pp |
| Q2 2025 | 2025-06-30 | −20.29% | −7.79 pp |
| Q1 2025 | 2025-03-31 | −15.62% | −3.45 pp |
| Q4 2024 | 2024-12-31 | −12.47% | +292.88 pp |
| Q3 2024 | 2024-09-30 | −11.12% | — |
| Q2 2024 | 2024-06-30 | −12.49% | — |
| Q1 2024 | 2024-03-31 | −12.17% | — |
| Q4 2023 | 2023-12-31 | −305.34% | — |
| Q3 2022 | 2022-09-30 | −21.98% | −5.92 pp |
| Q2 2022 | 2022-06-30 | −20.42% | −10.13 pp |
| Q1 2022 | 2022-03-31 | −66.38% | −55.36 pp |
| Q4 2021 | 2021-12-31 | −40.99% | −35.77 pp |
| Q3 2021 | 2021-09-30 | −16.07% | −13.11 pp |
| Q2 2021 | 2021-06-30 | −10.28% | −6.59 pp |
| Q1 2021 | 2021-03-31 | −11.02% | −8.06 pp |
| Q4 2020 | 2020-12-31 | −5.22% | +4.98 pp |
| Q3 2020 | 2020-09-30 | −2.96% | — |
| Q2 2020 | 2020-06-30 | −3.69% | — |
| Q1 2020 | 2020-03-31 | −2.96% | — |
| Q4 2019 | 2019-12-31 | −10.20% | — |
Korro Bio return on equity trends
Over the last five fiscal years, Korro Bio's return on equity decreased from −14.73% to −110.70%, a change of −95.96 percentage points. The latest reported quarter, Q2 2026, shows −16.98%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Korro Bio source filings ↗